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Abstract 
Background: Increased carotid intima-media thickness (CIMT), a marker of subclinical atherosclerosis, is an inde-
pendent predictor of future cardiovascular events, and has been reported in children with various chronic diseases, 
including type 1 diabetes mellitus (DM1).
Objectives: Evaluate CIMT and its association with cardiovascular risk factors in Brazilian adolescents with DM1.
Methods: Cross-sectional study of 118 adolescents, 57 with DM1 and no chronic complications related to the 
disease, and 61 healthy individuals. Clinical, biochemical, and high-resolution B-mode ultrasonographic evalua-
tions according to the Consensus Statement of the American Society of Echocardiography CIMT Task Force were 
performed.
Results: Adolescents with diabetes (66.6% female) were 14.5 ± 2.9 years old and had 9.0 ± 4.0 years of disease dura-
tion. The healthy adolescents (62.3% female) were 14.3 ± 2.6 years old. All the adolescents had blood pressure within 
their reference ranges. In 66% of DM1 adolescents the systolic blood pressure was >50th percentile. Increased CIMT 
was observed in adolescents with diabetes compared with those in the control group: 0.53 vs 0.51 mm (p < 0.004) on 
the right side, and 0.55 vs 0.51 mm (p < 0.001) on the left side. CIMT presented independent and positive associations 
with diabetes duration, total cholesterol level, low-density lipoprotein cholesterol level, and systolic blood pressure 
percentile in DM1 adolescents.
Conclusions: Increased CIMT was observed in young Brazilian adolescents with DM1, and was associated with car-
diovascular risk factors. CIMT assessment may be useful for the early identification and monitoring of cardiovascular 
risk in this age group.
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Background
Diabetes mellitus is associated with a high risk of cardio-
vascular disease (CVD). Carotid intima-media thickness 
(CIMT) is a noninvasive index of subclinical atheroscle-
rosis and is significantly increased in type 1 Diabetes 
Mellitus (DM1) patients as compared to control subjects 
[1]. Long-term diabetes-related complications account 
for most of the increased morbidity and mortality associ-
ated with the disease, and longitudinal studies indicated 
that atherosclerotic processes in the endothelium begin 
in childhood and progress rapidly in the presence of risk 
factors [2]. Therefore, special attention should be given to 
monitoring and controlling risk factors in children with 
diabetes because of their high risk of CVD in the future 
[3]. Carotid ultrasound has been used in the evaluation 
of intima-media thickness (IMT) due to its accessibility 
and low cost. Increased CIMT correlates with cardio-
vascular outcomes such as increased risk of stroke and 
coronary artery diseases [4]. Significant thickening of the 
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various chronic diseases, including DM1 [5, 6]. Factors 
such as age at DM1 onset, poor glycemic control, high 
levels of low-density lipoprotein cholesterol (LDL-C) and 
systolic blood pressure (SBP) have been associated with 
increased CIMT in pediatric patients [7]. However, the 
relationship between changes in intima-media thickness, 
and physiological or pathological conditions in childhood 
has not been fully elucidated. Moreover, as far as we 
know, no Brazilian data has been published on CIMT in 
DM1 adolescents. Therefore, this study aimed to evaluate 
CIMT and its relationship with cardiovascular risk fac-
tors in Brazilian adolescents with DM1 followed-up at a 
single university center.
Subjects and methods
This cross-sectional study was approved by the Institu-
tion Research Ethics Committee and the adolescents 
were included after agreeing to participate.
One hundred and eighteen adolescents were evaluated: 
57 DM1 patients and 61 healthy individuals.
From an universe of 320 potentially eligible patients 
with DM1, 57 adolescents 10–20 years old who had a dis-
ease duration  >5  years, and agreed to participate, were 
included in the study. They were diagnosed according 
the American Diabetes Association criteria [8], and had 
been in regular follow-up at the Pediatric Endocrinology 
Service of the University Hospital, under routine clinical 
and laboratory evaluation. None of them had history of 
chronic, autoimmune diseases or regular use of medica-
tion, but the diabetes. They had been under basal-bolus, 
intensive insulin regimen (most receiving NPH-ultra 
rapid insulin) of multiple daily doses. They had neither 
acute diabetic complications nor chronic diabetes-related 
macro or micro-vascular complications, such as diabetic 
neuropathy, retinopathy or nephropathy, as assessed by 
clinical evaluation, fundus examination or microalbumi-
nuria detection, respectively.
The healthy adolescents were recruited from a pub-
lic school, and matched to the DM1 group for age and 
gender. The inclusion criteria consisted of being in 
good health. The exclusion criteria were the presence or 
a history of any chronic disease, and continuous use of 
medication.
All participants underwent a clinical and biochemi-
cal evaluation. A complete physical examination was 
conducted by the same researcher. The anthropomet-
ric parameters assessed according to the World Health 
Organization (WHO) criteria were measured using 
portable digital scales (G-Tech®) to the nearest 0.1  kg 
for weight, and a wall-mounted stadiometer to the near-
est 0.1  cm for height [9]. The body mass index (BMI) 
Z-scores were classified according to the WHO estab-
lished criteria [9]. Pubertal staging for females breast 
development and for testes size/genitalia for males were 
evaluated using the Tanner criteria [10].
Blood pressure was measured with the subjects in the 
supine position, using a Tycos sphygmomanometer, and 
appropriate cuffs for each participant. Blood pressure 
was analyzed following the fourth report on the diagno-
sis, evaluation, and treatment of high blood pressure in 
children and adolescents, according to age and height 
[11] and according to the percentile distribution [12].
Following overnight fasting, blood samples were col-
lected between 7 and 8 a.m. for the biochemical assess-
ment. Serum total cholesterol (Total-C) and fractions, 
and triglycerides were measured by colorimetric methods 
(VITROS®  5.1 FS Chemistry System, Buckinghamshire, 
UK), and analyzed according to the I Guidelines for pre-
vention of atherosclerosis in childhood and adolescence 
[13]. The mean of the last three serum glycated hemo-
globin (HBA1c) values for each patient was obtained in 
the last year of follow-up. They were assessed (immuno-
turbidimetric assay) and analyzed according to the rec-
ommendations of the American Diabetes Association 
[14].
Assessment of carotid artery intima media thickness 
(CIMT)
High-resolution B-mode ultrasonography was performed 
by a single experienced specialist in radiology and diag-
nostic imaging to measure the intima-media layer thick-
ness and evaluate the colour Doppler flow characteristics 
of the carotid arteries. The recommendations of the Con-
sensus Statement from the American Society of Echocar-
diography Carotid Intima-Media Thickness Task Force 
were followed [15].
The exams were conducted using a Philips device 
model HD11XE, with a high-resolution multi-frequency 
linear transducer adjusted to 12  MHz. B-mode colour 
photographic and Doppler velocimetry documentation 
was performed using image-acquisition software Image 
Explorer 3.1 for Windows.
After resting for 10 min, the subjects were evaluated in 
the supine position with the neck slightly extended and 
inclined to 45°. Longitudinal and transverse sections of 
the right and left common carotid arteries (CCA), carotid 
bulbs, internal carotid arteries, and external carotid 
arteries were obtained using B-mode and colour Doppler 
ultrasound.
The ultrasound evaluation focused on the identifica-
tion of the intima-media layer and distinction of focal 
atherosclerotic plaques. Three measurements of the 
IMT of each right and left common carotid arteries were 
obtained in the 15 mm stretch below the bulb region, free 
from focal plaques, where the double lines pattern of the 
IMT can be clearly observed. Multiple measurements 
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were averaged to report a mean IMT value for each 
artery. Colour Doppler flow examination of the internal 
and external common carotid arteries was conducted 
using technical parameters specific to the carotid arter-
ies. Pulsed Doppler ultrasound was performed in the 
most distal segments of the internal and external com-
mon carotid arteries accessible to the exploratory probe 
with an insonation angle less than or equal to 60° to 
obtain quantitative information through spectral analy-
sis. The equipment settings used were the same as the 
ones used for the qualitative analysis.
Statistical analysis
For the analyses, the R version 2.15.0 and EpiInfo ver-
sion 6.04 software were used, in the public domain. Cat-
egorical and quantitative variables were described as 
frequencies, percentages, measures of central tendency 
(mean and median), and dispersion (standard devia-
tion). Comparisons between the response variables and 
binary covariates were performed by using the Student t 
test, when the usual model assumptions (normality and 
homoscedasticity) were met. Comparisons of variables 
with more than two categories were performed by using 
the F test (analysis of variance), as the assumption of 
normality was also satisfied. Normal distribution of the 
variables was tested using the Shapiro–Wilk test for nor-
mality and Levene test for homoscedasticity (homogene-
ity among the variances).
The Pearson correlation coefficients were calculated to 
compare outcome variables and quantitative covariates. 
The mean CIMT measurements were compared between 
the diabetic and control groups by using the Student t 
test.
A p < 0.05 was considered as statistically significant.
For the multivariate analysis, linear regression models 
were developed to explain each response variable. In the 
first step of fitting the regression model, all covariates 
with p  ≤  0.25 in the univariate analysis were included. 
The variables were then removed in a step-by-step pro-
cess up to the point the final model included only those 
with statistical significance (p ≤ 0.05) and clinical impor-
tance. The fitting was adjusted from the residue analysis.
Results
The 57 DM1 adolescents (66.6% female) were 
14.5  ±  2.9  years old and had disease duration of 
9.0 ± 4.0 years. Most of them (95%) had already started 
puberty and had normal weight for height (96.5%); only 
two patients were underweight according to the BMI per-
centile for age. Adolescents with DM1 had both SBP and 
diastolic blood pressure (DBP) within the normal range 
for age and height; 66% of them presented SBP  >50th 
percentile.
The clinical and biochemical characteristics of the ado-
lescents are presented in Table 1.
Most of DM1 adolescents (75%) had poor glycemic 
control. Only 35% showed Total-C levels within the refer-
ence range, and 66% showed triglyceride levels within the 
reference range.
The measurements of the right and left CIMT of the 
adolescents with DM1 are presented in Table  2. An 
increased CIMT on both sides was observed in adoles-
cents with DM1 as compared with the adolescents in the 
control group.
CIMT presented independent and positive associations 
with Total-C level, low-density lipoprotein cholesterol 
level (LDL-C), diabetes duration and SBP percentile in 
DM1 adolescents.
The Total-C and LDL-C concentrations showed mod-
erate and significant positive correlation with CIMT 
both on the right (r  =  0.397, p  <  0.002 and r  =  0.405, 
p  <  0.002 for Total-C and LDL-C, respectively) and 
left sides (r = 0.423, p < 0.001 and r = 0.463, p < 0.001, 
respectively).
High Total-C and LDL-C levels were significantly asso-
ciated with increased CIMT. CIMT measurements were 
lower in the patients presenting Total-C within the refer-
ence range, when compared to the patients showing high 
levels and, also to those presenting borderline values. The 
adolescents with DM1 with high Total-C levels showed 
Table 1 Clinical and Biochemical (mean ± SD) characteris-
tics of DM1 adolescents and healthy controls
SBP systolic blood pressure, DBP diastolic blood pressure (mm/Hg), NA not 
applicable
a Tanner 2/3 initial puberty; Tanner 4/5 advanced puberty
Characteristics Adolescent population p value
57 DM1 patients 61 healthy 
controls
Age (years) 14.5 ± 2.9 14.3 ± 2.6 1.0
Gender F 38 M 19 F 30 M 23 0.374
Puberty (Tanner)a
Initial 29 31 1.0
Advanced 28 30
Z BMI −0.40 ± 0.9 
(20.0 ± 2.4)
−0.40 ± 0.9 
(20.8 ± 2.2)
1.0
SBP 103.1 ± 10.2 110.1 ± 8.5 <0.001
DBP 66 ± 10.4 72 ± 7.2 <0.001
Triglycerides (mg/dL) 88.5 ± 46.5 72 ± 26.8 0.022
Total-C (mg/dL) 178.3 ± 31.9 148.5 ± 19.1 <0.001
LDL-C (mg/dL) 97.0 ± 24.3 84.7 ± 17.8 0.002
HDL-C (mg/dL) 61.4 ± 17.3 49.6 ± 8.4 <0.001
HbA1c 9.7 ± 2.0 NA
Duration of diabetes 
(m)
109.0 ± 35.6 NA
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CIMT = 0.57 ± 0.04 mm on the right side, whereas those 
with borderline values showed CIMT = 0.53 ± 0.05 mm, 
and those with Total-C within the reference range pre-
sented CIMT =  0.52 ±  0.04 mm (p < 0.012). The same 
association was observed on the left side.
The same trend was observed in the adolescents with 
DM1 with high LDL-C levels showing, on the left side, 
increased CIMT (0.59  ±  0.03  mm) associated to high 
LDL-C levels, whereas those patients with borderline val-
ues showed CIMT = 0.56 ± 0.04 mm, and those with val-
ues within the reference range CIMT = 0.54 ± 0.04 mm 
(p  <  0.015). On the right side, the adolescents pre-
sented CIMT  =  0.57  ±  0.03  mm, whereas those with 
borderline values showed CIMT  =  0.55  ±  0.06  mm. 
Those with values within the reference range showed 
CIMT = 0.52 ± 0.04 mm, not reaching statistical signifi-
cance (p < 0.119).
Diabetes duration showed a moderate and signifi-
cant positive correlation with CIMT both on the right 
(r = 0.414, p < 0.001) and left sides (r = 0.461, p < 0.001).
We didn’t find a significant association between CIMT 
and BP data both on the rigth (SBP: r = 0.153, p = 0.261, 
and DBP: r  =  0.168, p  =  0.214) and left sides (SBP: 
r = 0.243, p = 0.072, and DBP: r = 0.195, p = 0.150).
The SBP percentile was strongly correlated with CIMT 
on both sides (r = 0.768, p < 0.001 on the right side and 
r = 0.590, p < 0.001 on the left side). Moreover the ado-
lescents with SBP  >50th percentile showed significantly 
higher CIMT measurements than the patients with 
SBP ≤50th percentile in both the right (0.58 × 0.51 mm, 
p < 0.001) and left sides (0.58 × 0.53 mm, p < 0.001).
We found no association between the HBA1c and 
CIMT values.
A poor correlation was found between the BMI and 
CIMT values (r = 0.337, p < 0.010) and the triglyceride 
levels and CIMT values (r = 0.278, p < 0.036).
In the multivariate analysis DM1 adolescents with 
Total-C within the reference range showed, on average, 
a 0.03-unit less (95% CI 0.001–0.01) in CIMT measure-
ments on both sides, when compared with the patients 
with high cholesterol levels. CIMT measurements were 
not different when comparing patients with high Total-C 
levels and those presenting borderline values (p = 0.118 
on the right side and p = 0.089 on the left side).
The assessed CIMT increased by 0.006 unit on average 
(95% CI 0.001–0.01) on both the left and right sides, with 
each 10-unit increase in LDL-C concentration. On the 
left side, patients with LDL-C within the reference range 
had, on average, 0.04-unit less in CIMT as compared 
with the patients with high LDL-C values. CIMT meas-
urements were not different when comparing patients 
with high LDL-C levels and those presenting borderline 
values (p = 0.313).
A positive association was found between CIMT and 
diabetes duration: at every 10 months of the disease, the 
mean CIMT evaluated on both sides showed an average 
increase of 0.004 unit (95% CI 0.001–0.007).
The adolescents with DM1 with SBP  >50th percentile 
had, on average, a 0.06-unit increase in CIMT on the 
right, and a 0.05-unit increase on the left sides as com-
pared with the adolescents with SBP  ≤50th percentile 
(p < 0.001). The results of the multivariate analysis for the 
right and left carotid arteries are summarized in Tables 3 
and 4, respectively.
Discussion
In the present group of DM1 adolescents it was shown 
an increased CIMT when compared with the healthy 
controls of the same age, through a systematic assess-
ment by the same examiner, by using the same equip-
ment and technique. To our knowledge, this is the first 
study to investigate the values of CMIT in Brazilian ado-
lescents with DM1.We also observed that disease dura-
tion, higher concentrations of Total-C and LDL-C, and 
SBP >50th percentile were associated to the thickening of 
the carotid intima-media layer.
CVD remains as the leading cause of mortality in patients 
with diabetes in adulthood. The thickness of the intima-
media layer of the carotid arteries is a marker of subclini-
cal atherosclerosis and has been widely used to assess 
Table 2 Increased RCIMT and LCIMT values in 57 DM1 adolescents compared with 61 healthy controls
RCIMT right carotid intima media thickness, LCIMT left carotid intima media thickness
a Student t test
Characteristics n Mean ± SD Min 1Q Median 3Q Max p valuea
Right side
Patients 57 0.53 ± 0.05 0.45 0.51 0.53 0.58 0.66 0.004
Control group 61 0.51 ± 0.05 0.41 0.48 0.51 0.56 0.53
Left side
Patients 57 0.55 ± 0.04 0.47 0.51 0.54 0.58 0.64 <0.001
Control group 61 0.51 ± 0.04 0.44 0.48 0.51 0.55 0.61
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vascular health, including that of children with diabetes [6]. 
Increased CIMT in DM1 children has been related to early 
atherosclerosis changes [16, 17], and also been associated 
with diabetic microvascular complications as nephropathy 
and retinopathy [18, 19]. Abnormalities in myocardial func-
tion were recently reported, besides early vascular endothe-
lial dysfunction induced by DM1. It was also reported that 
early atherosclerotic changes in the adolescents were asso-
ciated with diabetic nephropathy, supporting that diabetic 
microangiopathy and macroangiopathy are related to each 
other in type 1 diabetic patients [20].
Although evaluation of CIMT as an early marker of 
atherosclerotic changes of the arterial wall has been rec-
ognized for >20 years in young DM1 patients [21] it has 
not been recommended in clinical practice. New pos-
sibilities to predict future cardiovascular events and 
endothelial dysfunction in DM1 children had already 
been reported but are not recommended [22].
It should be taken into consideration that an age- and 
puberty progression-related slight increase in the thick-
ness of the intima-media layer is reported in studies with 
healthy children and partly represents an adaptative 
Table 3 Association between the risk variables and RCIMT in 57 DM1 adolescents in the multivariate analysis
OR (confidence interval)
RCIMT right carotid intima media thickness
– not present in the model
Variables RCIMT
I II III IV
Categorical
 Total C
  Borderline −0.02 (−0.05 to 0.01) – – –
  Normal −0.03 (−0.06 to −0.003) – – –
 LDL-C
  Borderline – – – –
  Normal – – – –
  SBP percentile – – – 0.06 (0.05–0.08)
Quantitative
 DM1 duration 0.0004 (0.0001–0.0007) 0.0004 (0.0001–0.0007) 0.0004 (0.0001–0.0007) 0.0003 (0.0001–0.0005)
 Total C – 0.0004 (0.0001–0.0008) – –
 LDL-C – – 0.0006 (0.0001–0.001) –
Table 4 Association between the risk variables and LCIMT in 57 DM1 adolescents in the multivariate analysis
OR (confidence interval)
LCIMT left carotid intima media thickness
– not present in the model
Variables LCIMT
I II III IV V
Categorical
 Total C
  Borderline −0.02 (−0.05 to 0.003) – – – –
  Normal −0.03 (−0.05 to −0.003) – – – –
 LDL-C
  Borderline – – −0.02 (−0.06 to 0.02) – –
  Normal – – −0.04 (−0.08 to −0.01) – –
  SBP percentile – – – 0.05 (0.03–0.06)
Quantitative
 DM1 duration 0.0004 (0.0001–0.0007) 0.0004 (0.0001–0.0007) 0.0005 (0.0002–0.0008) 0.0004 (0.0001–0.0007) 0.0004 (0.0001–0.0006)
 Total C – 0.0004 (0.0001–0.0007) – – –
 LDL-C – – – 0.0006 (0.0002–0.001) –
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response to physiological increases in blood volume and 
pressure [23, 24]. The lack of standardization of CIMT val-
ues in this age group represents a hindrance to the wider 
use of CIMT measurements in the pediatric population.
However, a systematic review concluded that CIMT 
was significantly increased in 55 of the 67 studies, which 
included children with obesity, diabetes, hypertension, 
dyslipidemia, or chronic renal failure, despite assess-
ment difficulties in children and the heterogeneity of the 
methods used. This finding highlights the potential utility 
of carotid ultrasonography to identify vascular changes, 
besides reinforcing that early vascular damage occurs in 
the pediatric population, and that vascular lesions might 
be amenable to early detection [25].
Investigators had found evidence that CIMT is stabi-
lized or even decreased when cardiovascular risk factors 
such as hypercholesterolemia, glycemic control, or over-
weight are optimized, and this has also been shown in 
selected groups of pediatric patients [26].
Endothelial remodeling and consequent detection of 
carotid intima-media layer thickening in patients with 
diabetes are associated with longer disease duration, 
poor glycemic and lipid control, and high blood pressure 
[23, 27, 28].
We have shown that SBP percentile was associated 
with CIMT values, although DM1 adolescents evaluated 
in this study presented SBP and DBP within the normal 
ranges, according to reference standards. A strong asso-
ciation has been reported between increased CIMT in 
patients with DM1 and high SBP, stronger than that with 
LDL-C levels, family history of CVD, and diabetes dura-
tion [29, 30]. It had been suggested that among metabolic 
syndrome components, SBP is one of the most signifi-
cant factors associated with increased CIMT [30, 31]. 
Increased CIMT has already been reported in normo-
tensive children and adolescents with diabetes [32]. This 
finding supports the evidence that even normotensive 
individuals are at risk of arterial wall damage, depend-
ing on the degree of exposure to metabolic abnormali-
ties, which could be detected by CIMT measurements, 
as was found in this group of DM1 patients. The associa-
tion between the high-normal SBP values and increased 
intima-media thickness in normotensive adolescents 
might also support the existence of a continuous effect of 
blood pressure values on CIMT.
Other risk factors such as dyslipidemia are well estab-
lished in the physiopathological mechanism of athero-
sclerosis and associated to increased CIMT in patients 
with DM1 [29, 33] as we were able to show. In the dia-
betes control and complications trial/epidemiology of 
diabetes interventions and Complications study, LDL-C 
levels, formation of immune complexes, oxidized LDL 
levels, and final products of enzymatic glycosylation of 
LDL were significantly associated with the progression 
of CIMT [34]. Increased CIMT was also reported in 
children with familial hypercholesterolemia and homo-
cystinuria, metabolic diseases associated with premature 
atherosclerosis [35].
In the present study, an association between increased 
CIMT and borderline Total-C and LDL-C concentra-
tions, in addition to the association with the highest val-
ues, draws attention to the difficulty of characterizing 
normality criteria for evaluation of lipid concentrations, 
mainly in children.
An unexpected finding was the lack of association 
between the HBA1c levels and CIMT. The study pre-
sented, however, a limitation to this evaluation. The 
glycemic control in the adolescents with diabetes was 
assessed only in the last year of monitoring, which prob-
ably could not have reflected the control of the disease 
throughout its duration. In prospective studies, when 
the long-term effects of intensive glycemic control on 
the progression of atherosclerosis were evaluated, the 
mean HBA1c level was associated with increased CIMT 
[34]. The benefits of adequate glycemic control have been 
widely established in individuals exposed to chronic 
hyperglycemia [36].
Moreover, in this study, disease duration was associ-
ated with increased CIMT, probably reflecting cumulative 
endothelial damage after exposure to chronic hyperglyce-
mia and other risk factors since diagnosis. It was recently 
reported in patients with DM1 of long duration there was a 
0.4% increase in IMT for each year of disease duration [37], 
as we were also able to demonstrate. Age and diabetes dura-
tion had an additive effect on the IMT of DM1 patients.
Another limitation is the absence of CIMT measures in 
young adolescents having diabetic vascular complications 
to ensure comparisons with the studied group. However 
these patients are rare.
The importance of assessing CIMT in a pediatric popu-
lation is linked to the possibility of early intervention that 
leads to a better prognosis.
The reversibility of early atherosclerotic changes has 
already been reported in obese children who showed 
reduced CIMT after weight loss [26].
Guidelines have been established for screening for 
CVD risk factors in childhood, based on factors such as 
dyslipidemia, hypertension, and obesity. However, no 
consensus has been reached on the ideal age at which 
such screening should be conducted [38–40]. Although 
the reports on long-term outcome are still incipient, 
studies have suggested that therapeutic interventions in 
risk groups should be introduced as early as possible [41, 
42] to reduce prolonged exposure to hemodynamic and 
metabolic insults that can lead to an irreversible patho-
logical remodeling of the arterial wall.
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Patients with diabetes present, since childhood, sev-
eral factors that increase the risk of CVD, and it would be 
desirable that measures to identify, modify, and prevent 
the onset of cardiovascular events are taken early. The 
challenge lies in the absence of established parameters 
of normality for the evaluation of CIMT in this special 
age range, and also in the lack of a clear definition of the 
factors that influence its evolution, therefore prospective 
studies are needed.
It has been suggested that CIMT evaluation should be 
used at least as a tool for monitoring damage to target 
organs and therapeutic response in children and adoles-
cents with high cardiovascular risk until the methodol-
ogy for CIMT measurements is clearly defined [30]. Data 
presented here, also point in the same direction and rein-
force the need for monitoring and maintaining a strict 
metabolic control in DM1 adolescents.
Conclusion
Increased CIMT was observed in young Brazilian dia-
betic adolescents, and was associated with cardiovascular 
risk factors. We concluded that special attention should 
be given to early identification and monitoring of cardio-
vascular risk in young DM1 patients. CIMT assessment 
might be a useful instrument as CIMT has been consid-
ered an early sign of subclinical atherosclerosis  in type 
1 diabetes mellitus. Further longitudinal studies includ-
ing larger number of patients are needed to verify these 
results.
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